- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04449822
Emergency Surgery Versus Colorectal Stents for the Management of Malignant Colonic Obstructions
Emergency Surgery Versus Colorectal Stents for the Management of Malignant Colonic Obstructions: a Prospective Cohort Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Acute colonic obstruction is one of the common clinical presentations of colorectal cancer. Surgical decompression with colostomy with or without resection and eventual re-anastomosis is the treatment of choice; however, emergency surgery is associated with higher morbidity and mortality.
The colonic stent insertion effectively decompressed the obstructed colon and avoid needs of emergency surgery. This method is a palliation and bridge to surgery. Colonic stents allowed surgery to be performed electively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Yes
-
Tbilisi, Yes, Georgia, 0159
- Tbilisi State Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient with malignant colorectal obstructions.
- Patient's approval to participate in the study.
Exclusion Criteria:
- Patient's preference for either treatment method.
- Patient's refusal to participate in the study.
- Patients in the ASA group 4 and 5.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Emergency surgery
Surgical decompression with colostomy with or without resection and eventual re-anastomosis.
|
Surgical decompression with colostomy with or without resection and eventual re-anastomosis.
|
|
Active Comparator: Colonic stenting
The colonic stent placement
|
The colonic stent placement to relieve the colonic obstruction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The time of clinical relieve of obstruction
Time Frame: 24 hours after surgery/procedure
|
24 hours after surgery/procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stent related complications
Time Frame: time of hospital stay, an average 10 day.
|
perforation, migration, stent obstruction
|
time of hospital stay, an average 10 day.
|
|
Mortality
Time Frame: 30 day after surgery/procedure
|
30-day mortality
|
30 day after surgery/procedure
|
|
Blood loss
Time Frame: time of surgery/procedure
|
Blood loss during emergency surgery or during colonic stenting.
|
time of surgery/procedure
|
|
operation time
Time Frame: during surgery/procedure
|
duration of surgery/procedure
|
during surgery/procedure
|
|
Overall complications
Time Frame: 30 day after surgery/procedure
|
complications which developed in postoperative period
|
30 day after surgery/procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zaza Demetrashvili, Tbilisi State Medical University
Publications and helpful links
General Publications
- Merabishvili G, Agdgomelashvili I, Mosidze B, Demetrashvili Z. Emergency surgery versus colorectal stenting for the management of left-sided malignant colon obstructions:A prospective cohort study. Acta Scientific Medical Sciences 2021, 5(4):18-23. doi: 10.31080/ASMS.2020.05.0863
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07122017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.